Overview
Regulation / Supervision: CISA / FINMA (Funds for qualified investors).
Authorised investors: pension funds, insurance companies, family offices and institutional investors under CISA.
Investments: Equity securities issued by major companies in established markets worldwide, which are listed in the MSCI World ex Switzerland ESG Leaders.
Currently there are no investments in securities that are on the exclusion list of SVVK-ASIR (www.svvk-asir.ch).
Convertible and warrant bonds: none.
Portfolio is passively managed and aims to replicate the performance of the benchmark.
Currency exposure: in line with securities portfolio.
Securities lending: not permitted.
Use of derivatives: permitted under BVV2.
All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.
Risks
Features
| Product category |
Equity Global |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Legal form |
FCP
|
| Day of inception |
June 21, 2022
|
| Currency of account |
CHF
|
| Close of financial year |
October 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Flat fee |
0.14% p.a.
|
| Total expense ratio (TER) |
0.15% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI World ex Switzerland Selection (net div. reinv.)
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
111228168
|
| ISIN |
CH1112281683
|
| Bloomberg Ticker |
UBLPIA1 SW
|
| Telekurs Id |
EGEPIA1
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 1.93 | 3.35 | 3.05 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 5.37 | 6.27 | 20.53 |
| 3Y | 46.81 | 56.87 | 67.42 |
| 5Y | |||
| ø p.a.5Y | 13.65 | 16.19 | 18.74 |
Current data
| Net asset value | 23.04.2026 | CHF 1,492.05 |
| High - last 12 months | 15.01.2026 | CHF 1,522.68 |
| Low - last 12 months | 24.04.2025 | CHF 1,209.99 |
| Assets of the unit class in mn | 23.04.2026 | CHF 5.93 |
| Total product assets in mn | 23.04.2026 | CHF 1,079.61 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 11.46% | n.a. |
| Sharpe Ratio | 31.03.2026 | 0.34 | n.a. |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| NVIDIA Corp | 10.63 |
| Alphabet Inc | 7.69 |
| Microsoft Corp | 6.56 |
| Tesla Inc | 2.64 |
| Eli Lilly & Co | 1.85 |
| Johnson & Johnson | 1.48 |
| Visa Inc | 1.27 |
| ASML Holding NV | 1.25 |
| Mastercard Inc | 1.06 |
| Procter & Gamble Co/The | 0.84 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| AMAS Periodic Report |
|